Skip to main content
NCBI home page
Quality in Health Care : QHC logoLink to Quality in Health Care : QHC
. 1993 Jun;2(2):134–137. doi: 10.1136/qshc.2.2.134

Cholesterol screening and cholesterol lowering treatment.

T A Sheldon 1, F Song 1, G D Smith 1, N Freemantle 1, J Mason 1, A Long 1
PMCID: PMC1055099  PMID: 10131634

Full text

PDF
134

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Betteridge D. J., Dodson P. M., Durrington P. N., Hughes E. A., Laker M. F., Nicholls D. P., Rees J. A., Seymour C. A., Thompson G. R., Winder A. F. Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association. Postgrad Med J. 1993 May;69(811):359–369. doi: 10.1136/pgmj.69.811.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brett A. S. Psychologic effects of the diagnosis and treatment of hypercholesterolemia: lessons from case studies. Am J Med. 1991 Dec;91(6):642–647. doi: 10.1016/0002-9343(91)90218-m. [DOI] [PubMed] [Google Scholar]
  3. Broughton P. M., Bullock D. G., Cramb R. Quality of plasma cholesterol measurements in primary care. BMJ. 1989 Feb 4;298(6669):297–298. doi: 10.1136/bmj.298.6669.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cooper G. R., Myers G. L., Smith S. J., Schlant R. C. Blood lipid measurements. Variations and practical utility. JAMA. 1992 Mar 25;267(12):1652–1660. [PubMed] [Google Scholar]
  5. Havas S., Reisman J., Hsu L., Koumjian L. Does cholesterol screening result in negative labeling effects? Results of the Massachusetts Model Systems for Blood Cholesterol Screening Project. Arch Intern Med. 1991 Jan;151(1):113–119. [PubMed] [Google Scholar]
  6. Jones A., Davies D. H., Dove J. R., Collinson M. A., Brown P. M. Identification and treatment of risk factors for coronary heart disease in general practice: a possible screening model. Br Med J (Clin Res Ed) 1988 Jun 18;296(6638):1711–1714. doi: 10.1136/bmj.296.6638.1711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kannel W. B., Castelli W. P., Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med. 1979 Jan;90(1):85–91. doi: 10.7326/0003-4819-90-1-85. [DOI] [PubMed] [Google Scholar]
  8. Lefebvre R. C., Hursey K. G., Carleton R. A. Labeling of participants in high blood pressure screening programs. Implications for blood cholesterol screenings. Arch Intern Med. 1988 Sep;148(9):1993–1997. [PubMed] [Google Scholar]
  9. Martin M. J., Hulley S. B., Browner W. S., Kuller L. H., Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet. 1986 Oct 25;2(8513):933–936. doi: 10.1016/s0140-6736(86)90597-0. [DOI] [PubMed] [Google Scholar]
  10. Sackett D. L., Macdonald L., Haynes R. B., Taylor D. W. Labeling of hypertensive patients. N Engl J Med. 1983 Nov 17;309(20):1253–1253. doi: 10.1056/NEJM198311173092015. [DOI] [PubMed] [Google Scholar]
  11. Smith G. D., Shipley M. J., Marmot M. G., Rose G. Plasma cholesterol concentration and mortality. The Whitehall Study. JAMA. 1992 Jan 1;267(1):70–76. [PubMed] [Google Scholar]
  12. Smith G. D., Song F., Sheldon T. A. Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ. 1993 May 22;306(6889):1367–1373. doi: 10.1136/bmj.306.6889.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Smith W. C., Kenicer M. B., Davis A. M., Evans A. E., Yarnell J. Blood cholesterol: is population screening warranted in the UK? Lancet. 1989 Feb 18;1(8634):372–373. doi: 10.1016/s0140-6736(89)91736-4. [DOI] [PubMed] [Google Scholar]
  14. Stamler J., Wentworth D., Neaton J. D. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986 Nov 28;256(20):2823–2828. [PubMed] [Google Scholar]
  15. Stoate H. G. Can health screening damage your health? J R Coll Gen Pract. 1989 May;39(322):193–195. [PMC free article] [PubMed] [Google Scholar]
  16. Thompson S. G., Pocock S. J. The variability of serum cholesterol measurements: implications for screening and monitoring. J Clin Epidemiol. 1990;43(8):783–789. doi: 10.1016/0895-4356(90)90238-k. [DOI] [PubMed] [Google Scholar]
  17. Weissfeld J. L., Holloway J. J. Precision of blood cholesterol measurement and high blood cholesterol case-finding and treatment. J Clin Epidemiol. 1992 Sep;45(9):971–984. doi: 10.1016/0895-4356(92)90113-2. [DOI] [PubMed] [Google Scholar]

Articles from Quality in Health Care are provided here courtesy of BMJ Publishing Group

RESOURCES